Effects of transition metals on nitric oxide synthase catalysis
AUTOR(ES)
Perry, Jason M.
FONTE
The National Academy of Sciences
RESUMO
The biosynthesis of nitric oxide (NO) by the enzyme NO synthase (NOS) proceeds by the hydroxylation of l-arginine to form NG-hydroxy-l-arginine followed by the conversion of NG-hydroxy-l-arginine to l-citrulline and NO. The previously identified requirements of this relatively complicated reaction include several protein-bound cofactors: cytochrome P450-type heme, flavin mononucleotide (FMN), flavin adenine dinucleotide (FAD), and tetrahydrobiopterin (H4B). In addition to l-arginine, NOS also requires the substrates NADPH and molecular oxygen. The role of H4B in NOS catalysis has long been a subject of debate and uncertainty fueled, in part, by the failure to detect any dependence of the NOS reaction on nonheme iron, a cofactor integral to catalysis in every other H4B-dependent enzyme. Here we report the ability of NOS to bind transition metals stoichiometrically, and demonstrate that the rate of catalysis is enhanced by nonheme iron. We also show that other divalent transition metals, including Cu, Zn, Co, and Ni, inhibit NOS catalysis. Also, the addition of Cu2+ to NOS inhibits heme reduction, whereas the addition of Fe2+ does not. Overall, the results appear to connect NOS to the known H4B/nonheme iron-dependent hydroxylases, and suggest a similar, if not identical, step in the NOS reaction mechanism.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21602Documentos Relacionados
- Calmodulin phosphorylation and modulation of endothelial nitric oxide synthase catalysis
- Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis.
- RNA diversity has profound effects on the translation of neuronal nitric oxide synthase
- Direct measurement of nitric oxide generation from nitric oxide synthase
- The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta.